2 options
Regulation of the wnt signaling pathway in Xenopus laevis.
- Format:
- Book
- Thesis/Dissertation
- Author/Creator:
- Hedgepeth, Chester Melvin, III.
- Language:
- English
- Subjects (All):
- Biochemistry.
- Molecular biology.
- 0307.
- 0487.
- Penn dissertations--Cell and molecular biology.
- Cell and molecular biology--Penn dissertations.
- Local Subjects:
- Penn dissertations--Cell and molecular biology.
- Cell and molecular biology--Penn dissertations.
- 0307.
- 0487.
- Physical Description:
- 184 pages
- Contained In:
- Dissertation Abstracts International 59-11B.
- System Details:
- Mode of access: World Wide Web.
- text file
- Summary:
- Wnt signaling has been implicated in both axis determination and patterning of mesodermal tissue in Xenopus as well as the onset of cancer. A combination of genetic and biochemical approaches in multiple organisms has yielded the intracellular mediators of the pathway. They include frizzled, dishevelled, glycogen synthase kinase-3 beta (GSK-3beta), beta-catenin, APC, and Tcf-LEF family members. GSK-3beta is a serine-threonine kinase and a negative regulator of the wnt signaling pathway. Our work has focused on the regulation of GSK-3beta activity by lithium and a newly identified gene, axin. Lithium perturbs the development of a number of organisms including Dictyostelium, sea urchin, and Xenopus and it has been shown that lithium directly inhibits GSK-3beta, providing an potential explanation for its developmental actions. Here, we extend this finding to show that lithium can potently inhibit GSK-3beta activity in vivo resulting in an accumulation of beta-catenin protein and activation of the wnt signaling pathway. To prove that GSK-3beta is the only target of lithium important in mediating its developmental effects, we have designed a screen in Saccharomyces cerevisiae to identify mutants of MDS-1, a GSK-3beta homologue, which are resistant to lithium treatment. In addition, in a yeast two hybrid screen using GSK-3beta as bait, we have identified Xenopus axin. Axin is a maternal gene which is also expressed strongly in the anterior midbrain. In vivo, axin binds GSK-3beta and mutants of axin lacking key regulatory domains act as dominant negatives by binding GSK-3beta and inhibiting its activity. These mutant forms of axin provide alternative, in vivo GSK-3betaB inhibitors which mimic the effect of lithium. We also provide evidence that an axin-GSK-3beta complex is important in the regulation of GSK-3beta activity. Our data suggests that axin may mediate inhibition as well as activation of wnt signaling through its interactions with GSK-3beta.
- Notes:
- Thesis (Ph.D. in Cell and Molecular Biology) -- University of Pennsylvania, 1998.
- Source: Dissertation Abstracts International, Volume: 59-11, Section: B, page: 5709.
- Adviser: Peter S. Klein.
- Local Notes:
- School code: 0175.
- ISBN:
- 9780599120761
- Access Restriction:
- Restricted for use by site license.
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.